Strasbourg Oncologie Libérale - Clinique Sainte-Anne
- Address
- 182 route de la Wantzenau, 67000 STRASBOURG, Alsace, France
Male Urogenital Oncology
The department of Oncologie Médicale at Strasbourg Oncologie Libérale - Clinique Sainte‑Anne conducts research on castration‑resistant prostate cancer, focusing on improving survival and disease control through novel therapeutic combinations.
- Evaluation of overall survival benefit from low‑dose aspirin and atorvastatin
- Assessment of radiographic progression‑free survival with stereotactic radiation plus darolutamide versus darolutamide alone
- Use of functional PET imaging (PSMA, choline, fluciclovine) to guide treatment decisions
These studies aim to determine whether adding common cardiovascular agents or precise radiation techniques can extend life and delay progression for men with advanced prostate disease.
Hepatobiliary Oncology
Research in the Neoplasms area at the same site includes a trial targeting patients with high‑risk, resectable intrahepatic cholangiocarcinoma, exploring peri‑operative strategies to improve surgical outcomes.
- Investigation of peri‑operative chemotherapy combined with a targeted anti‑angiogenic regimen
- Measurement of progression‑free survival at 12 months as a primary endpoint
- Evaluation of postoperative recurrence rates and overall disease control
The goal is to enhance the chance of long‑term remission after liver resection by integrating systemic therapy before and after surgery.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 16 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Strasbourg Oncologie Libérale - Clinique Sainte-Anne
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparison of Apixaban, Rivaroxaban, and Acetylsalicylic Acid for Thromboembolic Prevention in JAK2V617F-Positive Myeloproliferative Neoplasms | Centre Hospitalier Regional Et Universitaire De Brest | Phase IV | Recruiting | Aug 2024 | — |
IMP list
lock Showing 1 of 16 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 2 | Unknown | 2019-06-26 | 2024-08-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.